8-K
Current Report
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000950170-25-033075
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading dnth-20250304.htm…